J Pødenphant Selected Research

Rheumatoid Arthritis

1/2019	Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
9/2017	Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
1/2017	Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.
9/2016	Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
4/2016	Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.
1/2015	Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
6/2014	Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
7/2008	Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Pødenphant Research Topics

Disease

8	Rheumatoid Arthritis 01/2019 - 07/2008
2	Synovitis 01/2019 - 09/2017
1	Osteitis 09/2017
1	Tenosynovitis 09/2017
1	Rheumatic Diseases (Rheumatism) 09/2016
1	Joint Diseases (Joint Disease) 01/2015
1	Necrosis 07/2008
1	Inflammation (Inflammations) 09/2000
1	Hip Osteoarthritis (Coxarthrosis) 09/2000
1	Pain (Aches) 09/2000
1	Stomach Ulcer (Gastric Ulcer) 09/2000

Drug/Important Bio-Agent (IBA)

4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 06/2014
3	GlucocorticoidsIBA 01/2019 - 06/2014
2	cyclic citrullinated peptideIBA 01/2019 - 01/2015
2	Anti-Citrullinated Protein AntibodiesIBA 01/2019 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2017 - 06/2014
2	Betamethasone (Celestone)FDA Link 09/2017 - 06/2014
2	Adalimumab (Humira)FDA Link 09/2016 - 04/2016
1	ametantrone (HAQ)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2017
1	C-Reactive ProteinIBA 09/2016
1	triamcinolone hexacetonide (Aristospan)FDA Link 09/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Circulating MicroRNAIBA 04/2016
1	EpitopesIBA 01/2015
1	AntibodiesIBA 01/2015
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2000
1	EnzymesIBA 09/2000
1	Diclofenac (SR 38)FDA LinkGeneric 09/2000
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2000
1	rofecoxib (Vioxx)FDA Link 09/2000

Therapy/Procedure

2	Therapeutics 09/2016 - 07/2008